ResMed (RMD) stock whipsawed Thursday after the CPAP maker reported better-than-expected December-quarter profit and narrowly beat sales forecasts.
The San Diego, Calif.-based maker of continuous positive airway pressure devices, or CPAPs, wrapped its fiscal second quarter with adjusted earnings of $2.43 per share and $1.28 billion in sales. Earnings surged more than 29% as sales advanced 10% on a year-over-year basis.
Both measures topped forecasts. Analysts surveyed by FactSet expected profit of $2.32 per share and $1.27 billion in sales.
"Our second quarter fiscal year 2025 top-line growth, margin expansion, and double-digit EPS growth were the result of increased demand for our sleep health and breathing health products and digital health solutions that people love, as well as our laser-focus on operational excellence," Chief Executive Mick Farrell said in a written statement.
https://www.investors.com/news/technology/resmed-stock-resmed-earnings-q2-2025/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.